PT1140102E - Compostos de triazinona para tratar doencas causadas por sarcosystis, neospora etoxoplasma - Google Patents

Compostos de triazinona para tratar doencas causadas por sarcosystis, neospora etoxoplasma

Info

Publication number
PT1140102E
PT1140102E PT99967434T PT99967434T PT1140102E PT 1140102 E PT1140102 E PT 1140102E PT 99967434 T PT99967434 T PT 99967434T PT 99967434 T PT99967434 T PT 99967434T PT 1140102 E PT1140102 E PT 1140102E
Authority
PT
Portugal
Prior art keywords
neospora
sarcosystis
etoxoplasma
diseases caused
treating diseases
Prior art date
Application number
PT99967434T
Other languages
English (en)
Inventor
Thomas J Kennedy
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of PT1140102E publication Critical patent/PT1140102E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT99967434T 1998-12-22 1999-12-18 Compostos de triazinona para tratar doencas causadas por sarcosystis, neospora etoxoplasma PT1140102E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/218,713 US6194408B1 (en) 1998-12-22 1998-12-22 Triazineone compounds for treating diseases due to Sarcocystis, Neospora and Toxoplasma

Publications (1)

Publication Number Publication Date
PT1140102E true PT1140102E (pt) 2004-10-29

Family

ID=22816196

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99967434T PT1140102E (pt) 1998-12-22 1999-12-18 Compostos de triazinona para tratar doencas causadas por sarcosystis, neospora etoxoplasma

Country Status (16)

Country Link
US (1) US6194408B1 (pt)
EP (1) EP1140102B1 (pt)
JP (1) JP4806121B2 (pt)
KR (1) KR100661102B1 (pt)
CN (1) CN1188128C (pt)
AT (1) ATE270891T1 (pt)
AU (1) AU770108B2 (pt)
BR (1) BR9916432A (pt)
CA (1) CA2356151C (pt)
DE (1) DE69918716T2 (pt)
ES (1) ES2226492T3 (pt)
HU (1) HU228994B1 (pt)
NZ (1) NZ512478A (pt)
PT (1) PT1140102E (pt)
WO (1) WO2000037064A2 (pt)
ZA (1) ZA200104205B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6469987B1 (en) 1998-01-13 2002-10-22 Enterasys Networks, Inc. Virtual local area network with trunk stations
AU766542B2 (en) * 1998-10-08 2003-10-16 New Ace Research Company Novel compositions and methods for prevention and treatment of protozoal disease
DE19958388A1 (de) * 1999-12-03 2001-06-07 Bayer Ag Triazinonverbindungen zur Behandlung von durch den Befall mit parasitischen Protozoen bedingten Krankheiten
EP1276499A2 (en) * 2000-04-25 2003-01-22 Wyeth Equine protozoal myeloencephalitis vaccine
DE10040110A1 (de) * 2000-08-17 2002-02-28 Bayer Ag Verwendung von Triazintrion-Sulfoxiden zur Bekämpfung von Coccidiosen
US6562007B1 (en) * 2000-09-28 2003-05-13 Bayer Healthcare Llc Adjustable dosage syringe
BRPI0406795A (pt) * 2003-01-16 2006-01-17 Janssen Pharmaceutica Nv Composições antiprotozoários que compreendem diclazuril
DE102007025908A1 (de) * 2007-06-01 2008-12-04 Bayer Healthcare Ag Formulierungen enthaltend Triazinone und Eisen
DE102009012423A1 (de) 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
KR101148098B1 (ko) * 2010-04-30 2012-05-22 한국화학연구원 1-［4-（4-니트로-페녹시）-페닐］-프로판-1-온을 유효성분으로 함유하는 톡소포자충 및 콕시디움에 기인한 질환의 예방 및 치료용 조성물
KR101242535B1 (ko) * 2010-10-05 2013-03-12 주식회사이-글벳 콕시듐 치료 및 예방을 위한 조성물의 제조방법
CN102772363B (zh) * 2012-08-22 2013-10-09 青岛康地恩药业股份有限公司 一种含泊那珠利的溶液剂及其制备方法
US10137111B2 (en) 2016-08-11 2018-11-27 Adamis Pharmaceuticals Corporation Drug compositions comprising an anti-parasitic and proton pump inhibitor
WO2019113493A1 (en) 2017-12-08 2019-06-13 Adamis Pharmaceuticals Corporation Drug compositions
WO2020093014A1 (en) * 2018-11-02 2020-05-07 Adamis Pharmaceuticals Corporation Drug compositions

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2313721A1 (de) * 1973-03-20 1974-10-03 Bayer Ag Neue 1-phenylsubstituierte 1,3,5triazine, verfahren zu ihrer herstellung, sowie ihre verwendung als arzneimittel
AU616916B2 (en) 1987-11-20 1991-11-14 Kissei Pharmaceutical Co. Ltd. 4h-quinolizin-4-one compounds exhibiting therapeutic activities
DE3826058A1 (de) 1988-07-30 1990-02-08 Bayer Ag Mittel gegen fischparasiten
US4933341A (en) * 1988-10-08 1990-06-12 Bayer Aktiengesellschaft Substituted 1,3,5-triazinetriones, for use against parasitic protozoa
US5196562A (en) 1988-10-08 1993-03-23 Bayer Aktiengesellschaft Substituted 1,3,5-triazinetriones, for use against parasitic protozoa
EP0377903A3 (de) 1989-01-09 1991-07-17 Bayer Ag Substituierte Hexahydro-1,2,4-triazindione, Verfahren zu ihrer Herstellung, Zwischenprodukte dafür und ihre Verwendung
CN1044905A (zh) 1989-02-16 1990-08-29 赫彻斯特股份公司 鱼和昆虫寄生虫对抗剂
DE4030042A1 (de) 1990-05-17 1991-11-21 Bayer Ag Verwendung von substituierten 1,2,4-triazindionen
DE4120138A1 (de) 1991-06-19 1992-12-24 Bayer Ag Substituierte hexahydro-1,2,4-triazindione, verfahren zu ihrer herstellung, zwischenprodukte dafuer und ihre verwendung
US5883095A (en) * 1997-08-07 1999-03-16 University Of Kentucky Research Foundation Formulations and methods to treat and prevent equine protozoal myeloencephalitis
BR9808114A (pt) * 1997-03-31 2000-03-08 David Granstrom Formulação de ração para cavalos utilizável para tratar epm, processos para tratar pm em um cavalo que necessita deste tratamento, para prevenir infecção com s. neutrona em cavalos, e, para exterminar s. neurona em cavalos
US5830893A (en) * 1997-04-23 1998-11-03 Mortar & Pestle Veterinary Pharmacy, Inc. Treatment of equine protozoan myeloencephalitis using triazinediones

Also Published As

Publication number Publication date
CN1331594A (zh) 2002-01-16
JP4806121B2 (ja) 2011-11-02
ES2226492T3 (es) 2005-03-16
KR20010087412A (ko) 2001-09-15
CA2356151A1 (en) 2000-06-29
WO2000037064A2 (en) 2000-06-29
HUP0104710A3 (en) 2003-10-28
JP2002532545A (ja) 2002-10-02
HUP0104710A2 (hu) 2002-04-29
EP1140102A2 (en) 2001-10-10
AU2370900A (en) 2000-07-12
AU770108B2 (en) 2004-02-12
ZA200104205B (en) 2002-05-22
CA2356151C (en) 2009-02-24
EP1140102B1 (en) 2004-07-14
BR9916432A (pt) 2001-09-04
CN1188128C (zh) 2005-02-09
HU228994B1 (en) 2013-07-29
HK1043315A1 (en) 2002-09-13
DE69918716T2 (de) 2005-08-04
ATE270891T1 (de) 2004-07-15
US6194408B1 (en) 2001-02-27
NZ512478A (en) 2003-07-25
KR100661102B1 (ko) 2006-12-26
DE69918716D1 (de) 2004-08-19
WO2000037064A3 (en) 2000-10-26

Similar Documents

Publication Publication Date Title
PT1140102E (pt) Compostos de triazinona para tratar doencas causadas por sarcosystis, neospora etoxoplasma
ATE303162T1 (de) Natrium kanalblocker zusammensetzungen und deren verwendung
LU91928I2 (fr) Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®)
EA200601281A1 (ru) Азабензофуранзамещенные тиомочевины; ингибиторы репликации вирусов
DE60036456D1 (de) Antimikrobiell wirksames oder endotoxin neutralisierendes polypeptid
NO990912D0 (no) Terapeutiske kombinasjoner av PAR-antagonister og RXR-antagonister og deres anvendelse
MY119375A (en) Treatment of tinnitus using neuroprotective agents
LV12291A (lv) Savienojums un farmaceitiskas kompozicijas ar triptazes aktivitates izmainam saistitu slimibu arstesanai
EE200200107A (et) Kiire algtoimega selektiivse serotoniini tagasihaaramise inhibiitori kasutamine ravimi valmistamiseks, mis on ette nähtud seksuaalse funktsioonihäireravimiseks
DE60039730D1 (de) Genetisch manipulierte Herpesviren zur Behandlung von Tumoren
GB0130677D0 (en) Medicaments and novel compounds
ATE339198T1 (de) Verwendung von 2-amino-2-(2-(4- octylphenyl)ethyl)propane-1,3-diol zur prävention oder behandlung viraler myocarditis
WO2000037063A3 (en) Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
TR200101245T2 (tr) N-arilsulfonil-aminoasit-omega-amidler
BR9916417A (pt) Compostos triazinaona para tratamento de doenças devidas à sarcosystis, neospora e toxoplasma
BR0110396A (pt) Métodos para prevenir e tratar alopecia induzida por quimioterapia ou radioterapia
EA200100930A1 (ru) Способ лечения хозл
PT1056458E (pt) Tratamento de dor cronica
DK1296686T3 (da) Praziquanatelsammensætninger til behandling af coccidiesygdomme
MXPA05013975A (es) Tratamiento de enfermedades asociadas con amiloide y epileptogenesis.
ATE248607T1 (de) Aminotetralin derivate zur therapie der kardiovaskulären erkrankungen
TNSN99158A1 (ar) طريقة لمنع الاصابة بالربو
BR9911150A (pt) Método de tratamento
EA200200846A1 (ru) Соединения, полезные для лечения или предупреждения заболеваний, опосредуемых альфа-2в-адреноцептором
EA200101043A1 (ru) Способ лечения неврологических или нейропсихиатрических расстройств